- Home
- ORMP
ORMP
Oramed Pharmaceuticals Inc.
as 10-22-2024 4:00pm EST
| Founded: | 2002 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 79.0K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.51 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.67 - $3.67 | Next Earning Date: | 11-07-2024 |
| Revenue: | N/A | Revenue Growth: | -50.43% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Oramed Pharmaceuticals Inc. News
ORMP Breaking Stock News: Dive into ORMP Ticker-Specific Updates for Smart Investing
MT Newswires
16 days ago
Scilex Holding Starts $50 Million Registered Direct Offering of Convertible Notes
PR Newswire
16 days ago
Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt
MT Newswires
a month ago
Scilex Holding to Pay $2 Million to Oramed Pharmaceuticals in Loan Accord
Zacks Small Cap Research
2 months ago
ORMP: Balance Sheet Strong, Potential Benefits of Investments, JVs, Buybacks
Associated Press Finance
2 months ago
Oramed: Q2 Earnings Snapshot
MT Newswires
4 months ago
Oramed Pharmaceuticals Board Approves $20 Million Share-Buyback Program
PR Newswire
4 months ago
Oramed Letter to Shareholders
PR Newswire
4 months ago
Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock
Compare ORMP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ORMP Oramed Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.